Make Medicines Affordable is a global campaign working in middle-income countries.
Why focus on middle-income countries?
Less than a third of the people in need of antiretroviral treatment in middle-income countries are currently able to access it.
By 2020, the vast majority of people living with HIV (87%) will be in high- and middle-income countries. Middle-income countries are home to almost half of the world’s population, and have a large and growing share of HIV infections (62%). They have even lower rates of antiretroviral treatment coverage than low-income countries.
One third of people living in middle-income countries survives on less than US$2 per day. Almost 6 million people in middle-income countries (excluding sub-Saharan Africa) need antiretroviral treatment. However, less than a third are currently able to access it.
Argentina has around 126,000 people living with HIV, of which fewer than 70,000 people are on antiretroviral therapy. The high prices of drugs limits the number of people who can get treatment.
In Brazil there are 780,000 people living with HIV, of which 405,000 are on HIV treatment. All patients get treatment free from the public health system which, as a result of the high price of drugs, is under severe strain.
An estimated half a million people live with HIV in Thailand. Of these people almost 300,000 are on HIV treatment under a national health insurance scheme paid for by the government.
Ukraine has over 250,000 people living with HIV, of which around 61,000 people are on antiretroviral therapy. According to the National Treatment Program over 118,000 people will be receiving treatment by 2018.
In the Asia-Pacific region, the number of people receiving antiretroviral therapy has increased to an estimated 39% of all people eligible.
Eastern Europe & Central Asia
Our campaigning in Eastern Europe and Central Asia is focused in Georgia, Kazakhstan and Moldova.
We work in Argentina, Brazil, Colombia, Mexico and Peru, where around 1.35 million people are living with HIV, half of which are on treatment.
Across Morocco, Tunisia and Egypt an estimated 43,600 people are living with HIV, and there is a significant treatment gap.
Southern Africa is home to roughly half of the world’s people living with HIV. Our work is focused in Zimbabwe, Botswana and Mauritius.
Over 2 million people are living with HIV in India. 1.7 million are registered in the antiretroviral program, and over 600,00 are on treatment.
Turning commitments and targets into reality in El Salvador. El Salvador has a HIV prevalence rate of 0.6%. An estimated...
Addressing gaps in data as a first step to securing essential medicines for people living HIV, Hepatitis C and TB....
Campaigning for optimal and increased treatment coverage in Guatemala to improve quality of life, decrease new infections and reduce stigma...
Working towards a sustainable approach for access to medicines in Georgia, particularly in light of the country preparing for Global...
Moldova’s government has committed to universal access to health services following the withdrawal of Global Fund support. Over-priced medicines are...
Patents on key HIV, Hepatitis C and TB drugs are preventing universal access in Vietnam. Our partner, VNP+, is advocating...
Working to close the significant treatment gap and see more people on optimal treatment in Russia. An estimated one million...
With a small population and low prevalence rates, universal access for HIV, Hepatitis C and TB should be easily achievable...
Tackling unmerited patents and over-pricing to support the government’s goal of universal access. There were 19,000 people living with HIV...
Building on the country’s new laws and guidelines to achieve everyone’s right to essential medicines – and at a fair...
Ensuring Kazakhstan’s national response to HIV, Hep C and TB is ‘fit-for-purpose’ and affordable. An estimated 27,000 people are living...
In Peru an estimated 66,000 people are living with HIV and according to latest reports less than half are on antiretroviral treatment.